The award money will come through the Biomedical Advanced Research and Development Authority, or BARDA, through the U.S. Department of Health and Human Services.
Moderna is set to receive $176 million from the U.S. government to develop a mRNA vaccine for bird flu in humans.
Read the full story
Calling for governments to enact a “global moratorium” on COVID-19 mRNA vaccines could have been a death sentence for a scientist’s career not long ago. Now it opens the door to a prestigious science publisher.
The Springer Nature medical journal Cureus, sibling to Nature and Scientific American, published a peer-reviewed paper by high-profile mRNA vaccine critics last month, showing the growing mainstream openness to data and arguments once nitpicked if not ignored by publishers and suppressed by academia and Big Tech.
Read the full story